IP Library › Granted Patent US 12,678,182
Granted Patent B2
US 12,678,182 · App. 17/659,605 · Granted Jul 14, 2026

Retrieval systems and methods for use thereof

Inventors: Brian B. Martin (Santa Cruz, CA); Martin S. Dieck (Campbell, CA)
Assignee: Covidien LP
A61B17/221A61B2017/22094A61B2017/2212A61B2017/2215
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,678,182
App. No.
17/659,605
Filed
Apr 18, 2022
Granted
Jul 14, 2026
Kind
B2
Art Unit
3771
USPC
606/200
Abstract

The devices and methods described herein relate to improved structures for removing obstructions from body lumens. Such devices have applicability in through-out the body, including clearing of blockages within the vasculature, by addressing the frictional resistance on the obstruction prior to attempting to translate and/or mobilize the obstruction within the body lumen.

Claims (41)

1 . A device system for removing an obstruction from a blood vessel, the system comprising:

a first elongate member having a first lumen;

a second elongate member arranged at least partially within the first lumen and having a second lumen, wherein at least a portion of the second elongate member is configured to have a radially expanded state upon release from the first elongate member;

an elongate shaft having a distal region, a proximal region, and a longitudinal axis extending between the distal and proximal regions; and

a capturing portion formed from a plurality of wires and configured to engage the obstruction, the capturing portion having a radially reduced state and a fully radially expanded state, wherein when the capturing portion is in the radially reduced state, at least a portion of the capturing portion is positionable in the second lumen, wherein when the capturing portion is in the fully radially expanded state, a length of the capturing portion measured along the longitudinal axis is greater than a largest diameter of the capturing portion measured perpendicular to the longitudinal axis, and wherein the capturing portion includes:

a first section fixed relative to the distal region of the elongate shaft, and

a second section connected to the first section and terminating in a free end unattached to another portion of the device other than the second section, and wherein a length of the second section is configured to atraumatically conform to a wall of the blood vessel when the capturing portion is in the fully radially expanded state,

wherein, when the elongate shaft is moved in a proximal direction, the first section inverts within the second section.

2 . The system of claim 1 , wherein the free end of the second section is unattached to the elongate shaft.

3 . The system of claim 1 , wherein the free end of the second section includes an opening, and the distal region of the elongate shaft extends through the opening.

4 . The system of claim 1 , wherein continued movement of the elongate shaft in the proximal direction causes the entire capturing portion to invert.

5 . The system of claim 1 , wherein the capturing portion is movable between:

a first configuration in which the first section is distal to the second section, and

a second configuration in which the first section is proximal to the second section.

6 . The system of claim 5 , wherein movement of the elongate shaft in the proximal direction causes the capturing portion to move from the first configuration toward the second configuration.

7 . The system of claim 1 , wherein the capturing portion comprises a mesh.

8 . The system of claim 1 , wherein the capturing portion is self-expanding.

9 . The system of claim 1 , further comprising a catheter having a catheter lumen.

10 . The system of claim 9 , wherein the elongate shaft extends through the catheter lumen.

11 . The system of claim 1 , further comprising a delivery sheath configured to introduce the capturing portion and the elongate shaft to a treatment site within the blood vessel proximate to the obstruction.

12 . The system of claim 1 , wherein the plurality of wires comprises one or more loops configured to atraumatically engage the wall of the blood vessel.

13 . The system of claim 1 , wherein the second elongate member comprises a body region and a distal portion distal to the body region, the distal portion forming a funnel having a maximum diameter larger than the body region.

14 . A system for removing an obstruction from a blood vessel, the system comprising:

a first elongate member having a first lumen;

a second elongate member arranged at least partially within the first lumen and having a second lumen, wherein at least a portion of the second elongate member is configured to have a radially expanded state upon release from the first elongate member;

an elongate shaft having a distal region, a proximal region, and a longitudinal axis extending between the distal and proximal regions; and

a capturing portion formed from a plurality of wires and configured to engage the obstruction, the capturing portion having a radially reduced state and a fully radially expanded state, wherein when the capturing portion is in the radially reduced state at least a portion of the capturing portion is positionable in the second lumen, wherein when the capturing portion is in the fully radially expanded state, a length of the capturing portion measured along the longitudinal axis is greater than a largest diameter of the capturing portion measured perpendicular to the longitudinal axis, and wherein the capturing portion includes:

a first section fixed relative to the distal region of the elongate shaft, and

a second section connected to the first section and terminating in a free end unattached to another portion of the device other than the second section, and wherein a length of the second section is configured to atraumatically conform to a wall of the blood vessel when the capturing portion is in the fully radially expanded state,

wherein the capturing portion is movable between:

a first configuration in which the first section is distal to the second section, and

a second configuration in which the first section is inverted within the second section.

15 . The system of claim 14 , wherein the free end of the second section is separate from the elongate shaft.

16 . The system of claim 14 , wherein the second section has a tubular shape with a lumen extending therethrough, and the distal region of the elongate shaft extends through the lumen.

17 . The system of claim 14 , wherein the capturing portion is configured to move from the first configuration toward the second configuration when the elongate shaft is moved in a proximal direction.

18 . The system of claim 14 , wherein, when the capturing portion is in the second configuration, the first section is proximal to at least a portion of the second section.

19 . The system of claim 14 , wherein the capturing portion is movable to a third configuration in which the second section is distal to the first section.

20 . The system of claim 14 , further comprising a catheter having a catheter lumen, wherein the elongate shaft extends through the catheter lumen.

21 . The system of claim 14 , further comprising a delivery sheath configured to introduce the capturing portion and the elongate shaft to a treatment site within the blood vessel proximate to the obstruction.

22 . The system of claim 21 , wherein the capturing portion is self-expanding upon deployment from the delivery sheath.

23 . The system of claim 12 , wherein the one or more loops are coupled to the distal region of the elongate shaft.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2022
From: MARTIN, BRIAN B.; DIECK, MARTIN S.
To: LAZARUS EFFECT, INC.
Reel/Frame 059744/0390 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2022
From: LAZARUS EFFECT LLC
To: COVIDIEN LP
Reel/Frame 059744/0401 →
CHANGE OF NAME Recorded Apr 30, 2022
From: LAZARUS EFFECT, INC.
To: LAZARUS EFFECT LLC
Reel/Frame 059858/0377 →
Continuity (5)
Continuation 15661383 · Jul 27, 2017
Continuation 14015741 · Aug 30, 2013
Continuation 12344378 · Dec 26, 2008
Provisional Application 61016651 · Dec 26, 2007
Related Publication 20220233207A1 · Jul 28, 2022
References Cited (99)
US 6146404A · Kim · 2000 [cited by examiner]
US 6214025B1 · Thistle · 2001 [cited by examiner]
US 6436120B1 · Meglin · 2002 [cited by examiner]
US 8545526B2 · Martin et al. · 2013 [cited by applicant]
US 8603014B2 · Alleman et al. · 2013 [cited by applicant]
US 8837800B1 · Bammer et al. · 2014 [cited by applicant]
US 9119656B2 · Bose et al. · 2015 [cited by applicant]
US 9126018B1 · Garrison · 2015 [cited by applicant]
US 9149609B2 · Ansel et al. · 2015 [cited by applicant]
US 9211132B2 · Bowman · 2015 [cited by applicant]
US 9241699B1 · Kume et al. · 2016 [cited by applicant]
US 9265512B2 · Garrison et al. · 2016 [cited by applicant]
US 9308007B2 · Cully et al. · 2016 [cited by applicant]
US 9399118B2 · Kume et al. · 2016 [cited by applicant]
US 9445828B2 · Turjman et al. · 2016 [cited by applicant]
US 9445829B2 · Brady et al. · 2016 [cited by applicant]
US 9492637B2 · Garrison et al. · 2016 [cited by applicant]
US 9539022B2 · Bowman · 2017 [cited by applicant]
US 9561345B2 · Garrison et al. · 2017 [cited by applicant]
US 9579119B2 · Cully et al. · 2017 [cited by applicant]
US 9585741B2 · Ma · 2017 [cited by applicant]
US 9642635B2 · Vale et al. · 2017 [cited by applicant]
US 9655633B2 · Leynov et al. · 2017 [cited by applicant]
US 9717514B2 · Martin et al. · 2017 [cited by applicant]
US 9737318B2 · Monstadt et al. · 2017 [cited by applicant]
US 9770251B2 · Bowman et al. · 2017 [cited by applicant]
US 9801643B2 · Hansen et al. · 2017 [cited by applicant]
US 9827084B2 · Bonnette et al. · 2017 [cited by applicant]
US 9861783B2 · Garrison et al. · 2018 [cited by applicant]
US 9993257B2 · Losordo et al. · 2018 [cited by applicant]
US 10028782B2 · Orion · 2018 [cited by applicant]
US 10029008B2 · Creighton · 2018 [cited by applicant]
US 10039906B2 · Kume et al. · 2018 [cited by applicant]
US 20010044634A1 · Don et al. · 2001 [cited by applicant]
US 20010051810A1 · Dubrul et al. · 2001 [cited by applicant]
US 20020072764A1 · Sepetka et al. · 2002 [cited by applicant]
US 20030176884A1 · Berrada et al. · 2003 [cited by applicant]
US 20040199201A1 · Kellett et al. · 2004 [cited by applicant]
US 20050159772A1 · Lowe et al. · 2005 [cited by applicant]
US 20050192620A1 · Cully et al. · 2005 [cited by applicant]
US 20050277977A1 · Thornton · 2005 [cited by examiner]
US 20060100662A1 · Daniel et al. · 2006 [cited by applicant]
US 20070112374A1 · Paul · 2007 [cited by examiner]
US 20080262532A1 · Martin · 2008 [cited by applicant]
US 20080312681A1 · Ansel et al. · 2008 [cited by applicant]
US 20130030461A1 · Marks et al. · 2013 [cited by applicant]
US 20130281788A1 · Garrison · 2013 [cited by applicant]
US 20140276074A1 · Warner · 2014 [cited by applicant]
US 20140343595A1 · Monstadt et al. · 2014 [cited by applicant]
US 20150359547A1 · Vale et al. · 2015 [cited by applicant]
US 20160015402A1 · Brady et al. · 2016 [cited by applicant]
US 20160015935A1 · Chan et al. · 2016 [cited by applicant]
US 20160106448A1 · Brady et al. · 2016 [cited by applicant]
US 20160106449A1 · Brady et al. · 2016 [cited by applicant]
US 20160113663A1 · Brady et al. · 2016 [cited by applicant]
US 20160113665A1 · Brady et al. · 2016 [cited by applicant]
US 20160151618A1 · Powers et al. · 2016 [cited by applicant]
US 20160157985A1 · Vo et al. · 2016 [cited by applicant]
US 20160199620A1 · Pokorney et al. · 2016 [cited by applicant]
US 20160296690A1 · Kume et al. · 2016 [cited by applicant]
US 20160302808A1 · Loganathan et al. · 2016 [cited by applicant]
US 20160375180A1 · Anzai · 2016 [cited by applicant]
US 20170079766A1 · Wang et al. · 2017 [cited by applicant]
US 20170079767A1 · Leon-Yip · 2017 [cited by applicant]
US 20170086862A1 · Vale et al. · 2017 [cited by applicant]
US 20170100143A1 · Grandfield · 2017 [cited by applicant]
US 20170105743A1 · Vale et al. · 2017 [cited by applicant]
US 20170164963A1 · Goyal · 2017 [cited by applicant]
US 20170215902A1 · Leynov et al. · 2017 [cited by applicant]
US 20170224953A1 · Tran et al. · 2017 [cited by applicant]
US 20170281909A1 · Northrop et al. · 2017 [cited by applicant]
US 20170290599A1 · Youn et al. · 2017 [cited by applicant]
US 20180049762A1 · Seip et al. · 2018 [cited by applicant]
US 20180084982A1 · Yamashita et al. · 2018 [cited by applicant]
US 20180116717A1 · Taff et al. · 2018 [cited by applicant]
US 20180132876A1 · Zaidat · 2018 [cited by applicant]
US 20180140314A1 · Goyal et al. · 2018 [cited by applicant]
US 20180140315A1 · Bowman et al. · 2018 [cited by applicant]
US 20180140354A1 · Lam et al. · 2018 [cited by applicant]
US 20180185614A1 · Garrison et al. · 2018 [cited by applicant]
US 20220240956A1 · Martin et al. · 2022 [cited by applicant]
EP 2319575B1 · 2013 [cited by applicant]
EP 1181900B1 · 2016 [cited by applicant]
JP 2014004219A · 2014 [cited by applicant]
JP 2018118132A · 2018 [cited by applicant]
KR 20180102877A · 2018 [cited by applicant]
WO WO2007079413 · 2007 [cited by examiner]
WO WO2008033845 · 2008 [cited by examiner]
WO 2015141317A1 · 2015 [cited by applicant]
WO 2017192999A1 · 2017 [cited by applicant]
WO 2018019829A1 · 2018 [cited by applicant]
WO 2018033401A1 · 2018 [cited by applicant]
WO 2018046408A2 · 2018 [cited by applicant]
WO 2018137029A1 · 2018 [cited by applicant]
WO 2018137030A1 · 2018 [cited by applicant]
WO 2018145212A1 · 2018 [cited by applicant]
WO 2018156813A1 · 2018 [cited by applicant]
WO 2018172891A1 · 2018 [cited by applicant]
WO 2018187776A1 · 2018 [cited by applicant]